SEC Comment Letter for Chemours Co (CC) (CIK 0001627223) (CC) — Apr 1, 2020
Chemours Co (CC) (CIK 0001627223)
Date: April 1, 2020 · CIK: 0001627223 · Accession: 0000000000-20-002802
AI Filing Summary & Sentiment
File numbers found in text: 001-36794
Letter
April 1, 2020 Sameer Ralhan Chief Financial Officer Chemours Co 1007 Market Street Wilmington, DE.19801 Re:Chemours Co Form 10-K for the year ended December 31, 2019 Filed February 14, 2020 File No. 001-36794 Dear Mr. Ralhan: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
April 1, 2020
Sameer Ralhan
Chief Financial Officer
Chemours Co
1007 Market Street
Wilmington, DE.19801
Re:Chemours Co
Form 10-K for the year ended December 31, 2019
Filed February 14, 2020
File No. 001-36794
Dear Mr. Ralhan:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences